EPB41L1
protein-codingerythrocyte membrane protein band 4.1 like 1, the group of Erythrocyte membrane protein band 4.1|FERM domain containing
Gene summary
Erythrocyte membrane protein band 4.1 (EPB41) is a multifunctional protein that mediates interactions between the erythrocyte cytoskeleton and the overlying plasma membrane. The encoded protein binds and stabilizes D2 and D3 dopamine receptors at the neuronal plasma membrane. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~141.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0015802
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0013658
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
*EPB41L1* encodes a neuronal cytoskeletal protein that mediates interactions between the cytoskeleton and membrane proteins including synaptic receptors. *EPB41L1* was first reported in relation to autosomal dominant non-syndromic intellectual disability (ID) in 2011 (Hamdan et al., PMID: 21376300). Hamdan et al. reported a *de novo* missense variant in an individual with severe ID and hypotonia with normal brain MRI. Functional studies revealed reduced binding of EPB41L1 to AMPA glutamate receptors, resulting in decreased receptor trafficking at the synaptic membrane (PMID: 21376300). At least five additional missense variants have been reported in exome sequencing studies in individuals with autism spectrum disorder or developmental disorders, four of which were *de novo* (PMIDs: 24467814, 25961944, 28344757, 33057194). These variants affect highly conserved positions and are predicted deleterious with various pathogenicity tools, but only two are absent from gnomAD; in the absence of functional studies they were not scored. A splice variant of unknown inheritance in a proband with autism (PMID: 31981491) was present 10 times in gnomAD v4.1.1, and was therefore not added as evidence. Large 20q11.2 deletions (>1.6 Mb) encompassing *EPB41L1* have been reported in individuals with ID, craniofacial dysmorphism, and anomalies of the extremities (PMID: 25572454). However, this evidence is insufficient to support pathogenicity due to *EPB41L1* haploinsufficiency. *EPB41L1* is intolerant to truncating variants (pLI = 1, LOEUF = 0.4; gnomAD v4.1.1) and missense variants (Z = 4.38). Since only one missense variant in *EPB41L1* has been reported in non-syndromic ID, we decided to curate for the more general term complex neurodevelopmental disorder. This gene-disease relationship is also supported by protein interactions with AMPA glutamate receptors implicated in ID and other neurodevelopmental disorders (GRIA1 and GRIA4). However, given the paucity of genetic evidence, this experimental evidence was not scored. In summary, there is limited evidence to support the relationship between *EPB41L1* and autosomal dominant complex neurodevelopmental disorder. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts this gene-disease relationship. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on July 6, 2022. It was reevaluated on August 24, 2026. As a result of this reevaluation, no additional patients were identified and the classification did not change. The scoring was updated to be consistent with SOP Version 12.
Inheritance Pattern: AD
Disease ID:MONDO:0013658
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EPB41L1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_012156.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 37 | 5 | 44 | ||
| missense | 1 | 118 | 25 | 2 | 146 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 5 | 1 | 6 | |||
| Total | 0 | 1 | 126 | 63 | 7 | 197 |
Highest pathogenic variant AF is 0.000008054563
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_036288.2 | 21 | MANE Select | |
| Ensembl | ENSP00000337168.2 | 21 | MANE Select | |
| RefSeq | NP_001245258.1 | 21 | Standard | |
| RefSeq | NP_001245259.1 | 19 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Splicing factor NOVA regulated synaptic proteins
- Neuronal System
- Neurexins and neuroligins
- Trafficking of AMPA receptors
- Glutamate binding, activation of AMPA receptors and synaptic plasticity
Biological Process
- cortical actin cytoskeleton organization
- actomyosin structure organization
Molecular Function
- actin binding
- structural molecule activity
- protein binding
Cellular Component
- cytosol
- cytoskeleton
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000338074
- Coding exons
- 21
- Length
- 141296
- Individuals with no LoFs
- 125731
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 17
- Defined
- 125748
- p
- 0.0000676
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.94 | 394 | 518 | 0.760 | 0.0000337 | 5781 |
| Missense (PolyPhen) | 116 | 216.23 | 0.53647 | 2487 | ||
| Synonymous | 1.73 | 183 | 215 | 0.850 | 0.0000143 | 1743 |
| Loss of Function | 4.87 | 8 | 42.1 | 0.190 | 0.00000207 | 516 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.000079 | 0.000079 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May function to confer stability and plasticity to neuronal membrane via multiple interactions, including the spectrin-actin-based cytoskeleton, integral membrane channels and membrane-associated guanylate kinases.;
Recessive Scores
- pRec
- 0.0936
Intolerance Scores
- LoFtool
- 0.0449
- RVIS EVS
- -0.73
- RVIS percentile EVS
- 14.15
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.839
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |